Mass Campaigns With Fractional Dose Pneumococcal Vaccines in Sub-Saharan Africa (fPCV) (fPCV)
Determining Whether Mass Campaigns With Fractional Dose PCV10 Would Accelerate Herd Protection Against Pneumococcal Transmission in Sub-Saharan Africa
Sponsor: Epicentre
Listed as NCT05175014, this PHASE4 trial focuses on Pneumococcal Carriage and remains completed. Sponsored by Epicentre, it has been updated 8 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Mar 2025 — Present [monthly]
Completed PHASE4
-
Jan 2025 — Mar 2025 [monthly]
Completed PHASE4
Status: Active Not Recruiting → Completed
-
Nov 2024 — Jan 2025 [monthly]
Active Not Recruiting PHASE4
-
Sep 2024 — Nov 2024 [monthly]
Active Not Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE4
▶ Show 3 earlier versions
-
Oct 2023 — Jul 2024 [monthly]
Active Not Recruiting PHASE4
Status: Recruiting → Active Not Recruiting
-
Jul 2022 — Oct 2023 [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Jan 2022 — Jul 2022 [monthly]
Not Yet Recruiting PHASE4
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Epicentre
- Kenya Medical Research Institute
- London School of Hygiene and Tropical Medicine
- Universite Abdou Moumouni de Niamey, Niger
For direct contact, visit the study record on ClinicalTrials.gov .